Registration number:
QMasters Medical Informatics Ltd
for the Period from 1 January 2024 to 31 March 2025
Pages for filing with Registrar
QMasters Medical Informatics Ltd
Contents
|
Company Information |
|
|
Balance Sheet |
|
|
Notes to the Unaudited Financial Statements |
QMasters Medical Informatics Ltd
Company Information
|
Directors |
Dr S L Greville-Heygate Dr R A Greville-Heygate Dr N Kamal |
|
Registered office |
|
|
Registered number |
08327861 |
|
Accountant |
|
QMasters Medical Informatics Ltd
(Registration number: 08327861)
Balance Sheet as at 31 March 2025
|
Note |
2025 |
2023 |
|
|
Fixed assets |
|||
|
Tangible assets |
- |
|
|
|
Investment property |
- |
|
|
|
Investments |
|
|
|
|
|
|
||
|
Current assets |
|||
|
Debtors |
|
|
|
|
Cash at bank and in hand |
- |
|
|
|
|
|
||
|
Creditors: Amounts falling due within one year |
( |
( |
|
|
Net current assets |
|
|
|
|
Total assets less current liabilities |
|
|
|
|
Provisions for liabilities |
( |
( |
|
|
Net assets |
|
|
|
|
Capital and reserves |
|||
|
Called up share capital |
|
100 |
|
|
Profit and loss account |
|
993,095 |
|
|
Total equity |
|
993,195 |
QMasters Medical Informatics Ltd
(Registration number: 08327861)
Balance Sheet as at 31 March 2025
For the financial period ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
|
• |
|
|
• |
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts. |
These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and FRS 102 ‘The Financial Reporting Standard Applicable in the UK and Republic of Ireland’.
These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.
Approved and authorised for issue by the
.........................................
Director
QMasters Medical Informatics Ltd
Notes to the Unaudited Financial Statements for the Period from 1 January 2024 to 31 March 2025
|
Statutory information |
The company is a private company limited by share capital, incorporated in England and Wales.
The address of its registered office is:
England
|
Accounting policies |
Summary of significant accounting policies
The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented.
Statement of compliance
These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.
Basis of preparation
These financial statements have been prepared using the historical cost convention.
The financial statements are prepared in pounds sterling which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
Going concern
The accounts have been prepared on a going concern basis which assumes that the company has sufficient funds to continue to trade for the foreseeable future and at least twelve months from the date of approval of these financial statements.
Disclosure of long period
Tax
The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.
The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.
QMasters Medical Informatics Ltd
Notes to the Unaudited Financial Statements for the Period from 1 January 2024 to 31 March 2025
Deferred tax
Deferred income tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred income tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.
The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.
Tangible fixed assets
Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.
Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:
|
Fixtures and fittings |
25% reducing balance |
|
Computer equipment |
25% reducing balance |
Investment property
Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and in hand.
Trade debtors
Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.
Trade creditors
Trade creditors are recognised at the transaction price.
QMasters Medical Informatics Ltd
Notes to the Unaudited Financial Statements for the Period from 1 January 2024 to 31 March 2025
Share capital
Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments.
Dividends
Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense.
The cost of any unused holiday entitlement is recognised in the period in which the employees' services are received.
|
Staff numbers |
The average number of persons employed by the company (including directors) during the period, was
QMasters Medical Informatics Ltd
Notes to the Unaudited Financial Statements for the Period from 1 January 2024 to 31 March 2025
|
Tangible fixed assets |
|
Furniture, fittings and equipment |
Computer equipment |
Total |
|
|
Cost |
|||
|
At 1 January 2024 |
|
|
|
|
Disposals |
( |
( |
( |
|
At 31 March 2025 |
- |
- |
- |
|
Depreciation |
|||
|
At 1 January 2024 |
|
|
|
|
Eliminated on disposal |
( |
( |
( |
|
At 31 March 2025 |
- |
- |
- |
|
Carrying amount |
|||
|
At 31 March 2025 |
- |
- |
- |
|
At 31 December 2023 |
|
|
|
|
Investment properties |
|
2025 |
|
|
At 1 January2024 |
|
|
Disposals |
( |
|
At 31 March2025 |
- |
QMasters Medical Informatics Ltd
Notes to the Unaudited Financial Statements for the Period from 1 January 2024 to 31 March 2025
|
Investments |
|
2025 |
2023 |
|
|
Investments in subsidiaries |
|
|
The investment represents a 51% holding in Ardens-Q Limited.
|
Debtors: amounts falling due within one year |
|
Note |
2025 |
2023 |
|
|
Amounts owed by group undertakings |
|
|
|
|
Prepayments |
- |
533 |
|
|
|
|
|
Creditors |
|
Note |
2025 |
2023 |
|
|
Amounts falling due within one year |
|||
|
Amounts owed to group undertakings |
|
|
|
|
Accruals |
1,750 |
2,460 |
|
|
Corporation tax |
2,165 |
5,583 |
|
|
Directors' loan accounts |
- |
2,372 |
|
|
|
|
QMasters Medical Informatics Ltd
Notes to the Unaudited Financial Statements for the Period from 1 January 2024 to 31 March 2025
|
Share capital |
Allotted, called up and fully paid shares
|
2025 |
2023 |
|||
|
No. |
£ |
No. |
£ |
|
|
|
|
100.00 |
- |
- |
|
|
- |
- |
|
50.00 |
|
|
- |
- |
|
50.00 |
|
|
|
|
|
|
On 29 October the 500 Ordinary A shares and 500 Ordinary B shares were redesignated to Ordinary shares by special resolution.
Each share has full voting rights, entitlement to receive dividends and entitled to a return of capital in the event of a winding up of the company.
|
Dividends |
|
2025 |
2023 |
|
|
Dividend of £ |
- |
- |
|
Dividend of £ |
|
|
|
Dividend of £ |
|
|
|
|
|